Pulmonary Valve Implantation With the New Shelhigh Injectable Stented Pulmonic Valve Stefano M. Marianeschi, MD, Francesco Santoro, MD, Elena Ribera, MD, Emanuele Catena, MD, Gabriele Vignati, MD, Simone Ghiselli, MD, Stefano Pedretti, MD, Ozkan Suleyman, MD, Hasim Ustunsoy, MD, Pascal A. Berdat, MD The Annals of Thoracic Surgery Volume 86, Issue 5, Pages 1466-1472 (November 2008) DOI: 10.1016/j.athoracsur.2008.06.085 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Injectable Pulmonic Valve Shelhigh NR-4000PA-MIS. Reprinted with permission of Shelhigh Inc. The Annals of Thoracic Surgery 2008 86, 1466-1472DOI: (10.1016/j.athoracsur.2008.06.085) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Example of a magnetic resonance image volume by frame curve of 1 patient (A) preoperatively and (B) postoperatively. (A) In the right ventricle (RV), systole is delayed, in (B) the RV function after 7 months from the implant is quantitatively and qualitatively similar to the left ventricle. The synchronization also is improved and the minimum RV volume during systole is reached in shorter time. The Annals of Thoracic Surgery 2008 86, 1466-1472DOI: (10.1016/j.athoracsur.2008.06.085) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Example of echocardiographic assessment of the valve and right ventricular (RV) function 7 months after implantation. (A, B) Valve position and normal right ventricular outflow tract (RVOT) flow velocity are shown. (C, D) Right ventricular motion of the tricuspid annulus (Strain) recovered to normal. (PA = pulmonary artery; RA = right atrium.) The Annals of Thoracic Surgery 2008 86, 1466-1472DOI: (10.1016/j.athoracsur.2008.06.085) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions